BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 27538511)

  • 1. Arginine Deiminase Enzyme Evolving as a Potential Antitumor Agent.
    Somani RR; Chaskar PK
    Mini Rev Med Chem; 2018; 18(4):363-368. PubMed ID: 27538511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pegylated arginine deiminase (ADI-SS PEG20,000 mw) inhibits human melanomas and hepatocellular carcinomas in vitro and in vivo.
    Ensor CM; Holtsberg FW; Bomalaski JS; Clark MA
    Cancer Res; 2002 Oct; 62(19):5443-50. PubMed ID: 12359751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of arginosuccinate synthetase (ASS) expression affects the antiproliferative activity of arginine deiminase (ADI) in melanoma cells.
    Manca A; Sini MC; Izzo F; Ascierto PA; Tatangelo F; Botti G; Gentilcore G; Capone M; Mozzillo N; Rozzo C; Cossu A; Tanda F; Palmieri G
    Oncol Rep; 2011 Jun; 25(6):1495-502. PubMed ID: 21424129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arginine deprivation as a targeted therapy for cancer.
    Feun L; You M; Wu CJ; Kuo MT; Wangpaichitr M; Spector S; Savaraj N
    Curr Pharm Des; 2008; 14(11):1049-57. PubMed ID: 18473854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aspergillus nidulans thermostable arginine deiminase-Dextran conjugates with enhanced molecular stability, proteolytic resistance, pharmacokinetic properties and anticancer activity.
    El-Sayed ASA; Shindia AA; Zeid AAA; Yassin AM; Sitohy MZ; Sitohy B
    Enzyme Microb Technol; 2019 Dec; 131():109432. PubMed ID: 31615671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid evolution of arginine deiminase for improved anti-tumor activity.
    Ni Y; Liu Y; Schwaneberg U; Zhu L; Li N; Li L; Sun Z
    Appl Microbiol Biotechnol; 2011 Apr; 90(1):193-201. PubMed ID: 21221572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Combination of Arginine Deprivation and 5-Fluorouracil Improves Therapeutic Efficacy in Argininosuccinate Synthetase Negative Hepatocellular Carcinoma.
    Thongkum A; Wu C; Li YY; Wangpaichitr M; Navasumrit P; Parnlob V; Sricharunrat T; Bhudhisawasdi V; Ruchirawat M; Savaraj N
    Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28587170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arginine deiminase: recent advances in discovery, crystal structure, and protein engineering for improved properties as an anti-tumor drug.
    Han RZ; Xu GC; Dong JJ; Ni Y
    Appl Microbiol Biotechnol; 2016 Jun; 100(11):4747-60. PubMed ID: 27087524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pancreatic cancer cell lines deficient in argininosuccinate synthetase are sensitive to arginine deprivation by arginine deiminase.
    Bowles TL; Kim R; Galante J; Parsons CM; Virudachalam S; Kung HJ; Bold RJ
    Int J Cancer; 2008 Oct; 123(8):1950-5. PubMed ID: 18661517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arginine Deiminase: Current Understanding and Applications.
    Zarei M; Rahbar MR; Morowvat MH; Nezafat N; Negahdaripour M; Berenjian A; Ghasemi Y
    Recent Pat Biotechnol; 2019; 13(2):124-136. PubMed ID: 30569861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purification, immobilization, and biochemical characterization of l-arginine deiminase from thermophilic Aspergillus fumigatus KJ434941: anticancer activity in vitro.
    El-Sayed AS; Hassan MN; Nada HM
    Biotechnol Prog; 2015; 31(2):396-405. PubMed ID: 25582958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pegylated arginine deiminase: a novel anticancer enzyme agent.
    Feun L; Savaraj N
    Expert Opin Investig Drugs; 2006 Jul; 15(7):815-22. PubMed ID: 16787144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arginine deprivation by arginine deiminase of Streptococcus pyogenes controls primary glioblastoma growth in vitro and in vivo.
    Fiedler T; Strauss M; Hering S; Redanz U; William D; Rosche Y; Classen CF; Kreikemeyer B; Linnebacher M; Maletzki C
    Cancer Biol Ther; 2015; 16(7):1047-55. PubMed ID: 25774632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of arginine deiminase from Pseudomonas plecoglossicida CGMCC2039 in Escherichia coli and its anti-tumor activity.
    Ni Y; Li Z; Sun Z; Zheng P; Liu Y; Zhu L; Schwaneberg U
    Curr Microbiol; 2009 Jun; 58(6):593-8. PubMed ID: 19280262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Engineering an arginine catabolizing bioconjugate: Biochemical and pharmacological characterization of PEGylated derivatives of arginine deiminase from Mycoplasma arthritidis.
    Wang M; Basu A; Palm T; Hua J; Youngster S; Hwang L; Liu HC; Li X; Peng P; Zhang Y; Zhao H; Zhang Z; Longley C; Mehlig M; Borowski V; Sai P; Viswanathan M; Jang E; Petti G; Liu S; Yang K; Filpula D
    Bioconjug Chem; 2006; 17(6):1447-59. PubMed ID: 17105223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crystal structures of arginine deiminase with covalent reaction intermediates; implications for catalytic mechanism.
    Das K; Butler GH; Kwiatkowski V; Clark AD; Yadav P; Arnold E
    Structure; 2004 Apr; 12(4):657-67. PubMed ID: 15062088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted cellular metabolism for cancer chemotherapy with recombinant arginine-degrading enzymes.
    Kuo MT; Savaraj N; Feun LG
    Oncotarget; 2010 Aug; 1(4):246-51. PubMed ID: 21152246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal cell carcinoma does not express argininosuccinate synthetase and is highly sensitive to arginine deprivation via arginine deiminase.
    Yoon CY; Shim YJ; Kim EH; Lee JH; Won NH; Kim JH; Park IS; Yoon DK; Min BH
    Int J Cancer; 2007 Feb; 120(4):897-905. PubMed ID: 17096330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Directed evolution of an antitumor drug (arginine deiminase PpADI) for increased activity at physiological pH.
    Zhu L; Tee KL; Roccatano D; Sonmez B; Ni Y; Sun ZH; Schwaneberg U
    Chembiochem; 2010 Mar; 11(5):691-7. PubMed ID: 20157910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amino Acids Sequence-based Analysis of Arginine Deiminase from Different Prokaryotic Organisms: An In Silico Approach.
    Abdollahi S; Morowvat MH; Savardashtaki A; Irajie C; Najafipour S; Zarei M; Ghasemi Y
    Recent Pat Biotechnol; 2020; 14(3):235-246. PubMed ID: 32208128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.